A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
NCT06819865 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-05-01
Summary
This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Conditions
- Acute Pulmonary Embolism
Interventions
- DEVICE
-
EkoSonicTM Endovascular System
EkoSonicTM Endovascular System and its upgraded versions if applicable The EkoSonicTM Endovascular System is a non-implanted system comprising a sterile, single-use EkoSonic Endovascular Device (Infusion Catheter and Ultrasonic Core) and reusable EKOSTM Control System 4.0(Control Unit, Connector Interface Cable and power cord).
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Guangqi Chang, Doctor · First Affiliated Hospital, Sun Yat-Sen University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-30
- Primary Completion
- 2027-03-30
- Completion
- 2028-07-30
- FDA Device
- Yes
More Related Trials
-
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
NCT00869024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure
NCT00721045 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System
NCT00626314 ·Status: UNKNOWN ·Phase: PHASE2
-
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease
NCT04551456 ·Status: UNKNOWN ·Phase: PHASE2
-
Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDS
NCT03608592 ·Status: UNKNOWN ·Phase: NA
-
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction
NCT04056819 ·Status: COMPLETED ·Phase: PHASE1
-
Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
NCT02368587 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
NCT02504437 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease
NCT04052191 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
NCT04657458 ·Status: NO_LONGER_AVAILABLE
-
Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia
NCT01456819 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
NCT06364150 ·Status: RECRUITING ·Phase: PHASE3
-
Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study
NCT03397095 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
NCT05689008 ·Status: UNKNOWN ·Phase: PHASE3
-
Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure
NCT06002841 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Cell Therapy for Ischemic Heart Failure
NCT01353690 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
NCT02993809 ·Status: UNKNOWN ·Phase: PHASE1
-
Intraosseous Infusion in Hematologic Critical Patients
NCT07239375 ·Status: RECRUITING
-
Treating Heart Failure With hiPSC-CMs
NCT05223894 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes
NCT03343782 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety & Effects of Autologous ADSCs During Recovery Phase of ST-Elevation MI Effects of Autologous ADSC Implantation During Subacute Recovery Phase of ST-Elevation Myocardial Infarction
NCT03272191 ·Status: WITHDRAWN ·Phase: NA
-
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
NCT04909879 ·Status: WITHDRAWN ·Phase: PHASE2
-
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
NCT00050765 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
NCT00114452 ·Status: COMPLETED ·Phase: PHASE1